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PMS32 Pfizer, Bogota´, Colombia
PMS33 Bristol-Myers Squibb, Lima, Peru
PMS34 None
PMS35 Laboratorios Corne, Mexico City, Mexico
PMS36 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA




PMS41 Savient Pharmaceuticals, East Brunswick, NJ, USA
PMS42 None
PMS43 None
PMS44 Amgen Inc., Thousand Oaks, CA, USA
PMS45 None
PMS46 Immunex Corporation, a wholly owned subsidiary of Amgen Inc., Newbury
Park, CA, USA; Wyeth, which was acquired by Pfizer Inc., New York, NY,
USA
PMS47 Centocor R&D Inc, Malvern, PA, USA
PMS48 AHW, Edmonton, AB, Canada




PMS53 UCB, Smyrna, GA, USA
PMS54 Pfizer Inc, New York, NY, USA
PMS56 None
PMS57 Centocor R&D Inc, Malvern, PA, USA
PMS58 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PMS60 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PMS61 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PMS62 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PMS63 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PMS64 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PMS65 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PMS66 Centocor R&D Inc, Malvern, PA, USA
PMS67 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PMS68 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PMS69 Costello Medical Consulting, Cambridge, UK




PMS74 Eli Lilly and Company, Indianapolis, IN, USA
PND1 None
PND2 Biogen Idec, Wellesley, MA, USA
PND3 EMD Serono, Inc., Rockland, MA, USA; Pfizer, Inc., New York, NY, USA
PND4 Cephalon, Inc., Frazer, PA, USA





PND10 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
PND11 None
PND12 Cephalon, Inc., Frazer, PA, USA
PND13 Eisai Inc, Woodcliff Lake, NJ, USA
PND14 Eisai Inc, Woodcliff Lake, NJ, USA
PND15 Pfizer, Collegeville, PA, USA
PND16 CSL Behring, King of Prussia, PA, USA; Baxter Healthcare Corporation,
Deerfield, IL, USA; Bayer Foundation, Pittsburgh, PA, USA; Novo Nordisk
Inc., Princeton, NJ, USA; Pfizer (Wyeth), New York, NY, USA
PND17 Biogen Idec, Boston, MA, USA
PND18 Biogen Idec, Boston, MA, USA
PND19 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
PND20 Novartis Pharmaceuticals, East Hanover, NJ, USA
PND21 Teva, Kansas City, MO, USA
PND22 None
PND23 Hospira Canada, St-Laurent, QC, Canada
PND24 None
PND25 Biogen Idec, Wellsley, MA, USA
PND26 Biogen Idec, Wellsley, MA, USA
PND27 UCB, Brussels, Belgium
PND28 Teva Pharmaceuticals, Kansas City, MO, USA
PND29 Neurosearch, Göteberg, Sweden
PND30 Allergan, Inc., Irvine, CA, USA
PND31 Allergan, Inc., Irvine, CA, USA
PND32 Allergan, Inc., Irvine, CA, USA
PND33 Pfizer (Wyeth), New York, NY, USA
PND34 GlaxoSmithKline, Research Triangle Park, NC, USA
PND35 Biogen Idec, Wellsley, MA, USA
PND36 Biogen Idec Inc., Weston, MA, USA
PND37 Teva Neuroscience, Kansas City, MO, USA
PND38 EMD Serono, Inc., Rockland, MA, USA; Pfizer, Inc., New York, NY, USA
PND39 Biogen Idec Inc., Weston, MA, USA
PND40 EMD Serono, Inc., Rockland, MA, USA; Pfizer, Inc., New York, NY, USA
PND41 University of Houston, Houston, TX, USA
PND42 None
PND43 UCB Pharma S.A., Brussels, Belgium
PND44 Ipsen US, Brisbane, CA, USA
PND45 Biogen Idec Inc., Weston, MA, USA
PND46 Eisai In, Woodcliff Lake, NJ, USA
PND47 Pfizer (Wyeth), New York, NY, USA
PND48 None
PND49 None
PND50 Biogen Idec GmbH, Wellesley, MA, USA
PND51 EMD Serono, Inc., Rockland, MA, USA; Pfizer, Inc, New London, CT, USA
PND52 Cephalon, Inc., Frazer, PA, USA
PND53 GlaxoSmithKline, Research Triangle Park, NC, USA
PND54 Bayer HealthCare Pharmaceuticals, Inc., Wayne, NJ, USA
PND55 None




PND60 San Francisco State University, San Francisco, CA, USA
PND61 None






PRM3 Costello Medical Consulting Ltd., Cambridge, UK
PRM4 None
PRM5 None
PRM6 National Science Council, Taipei, Taiwan
PRM7 None
PRM8 None
PRM9 Health Development Institute, Astana, Kazakhstan
PRM10 Cegedim Strategic Data Medical Research Ltd., London, United Kingdom;
Pfizer, London, UK




PRM15 Kantar Health, New York, NY, USA
PRM16 Eli Lilly and Company, Indianapolis, IN, USA
PRM17 None
PRM18 None
PRM19 Merck & Co., Inc., North Wales, PA, USA
PRM20 National Institute for Nursing Research, Bethesda, MD, USA
PRM21 None
PRM22 Merck & Co., Inc., North Wales, PA, USA
PRM23 Allergan Inc., Markham, ON, Canada
PRM24 Merck & Co., Inc, North Wales, PA, USA
PRM25 QualityMetric Incorporated, Lincoln, RI, USA
PRM26 Walgreens, Deerfield, IL, USA
PRM27 US Consumer Product Safety Commission, Bethesda, MD, USA; Veteran’s



















PRM47 Double Helix Consulting, London, UK
PRM48 None
PRM49 Pfizer, New London, CT, USA
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PRS3 Novartis, Paris, France
PRS4 Lovelace Respiratory Research Institute, Albuquerque, NM, USA
PRS5 None
PRS6 None
PRS7 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
PRS8 Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA
PRS9 None
PRS10 Pfizer, San Jose, Costa Rica
PRS11 Food Allergy and Anaphylaxis Network, McLean, VA, USA
PRS12 Novartis Korea, Seoul, South Korea
PRS13 Pfizer Animal Health Inc., Madison, NJ, USA
PRS14 Novartis Pharmaceuticals, Mexico City, Mexico
PRS15 GSK, Mexico, Mexico
PRS16 Pfizer, San Jose, Costa Rica
PRS17 None
PRS18 MSD Ltd, Hoddesdon, UK
PRS19 Pfizer, La Aurora, Costa Rica
PRS20 Novartis Pharmaceuticals, Mexico City, Mexico
PRS21 Boehringer Ingelheim, Sao Paulo, Brazil
PRS22 Glaxosmithkline, DURHAM, NC, USA
PRS23 Society of Infectious Diseases Pharmacists, Austin, TX, USA
PRS24 None
PRS25 Forest Research Institute, Jersey City, NJ, USA
PRS26 Merck, Whitehouse Station, NJ, USA; Boehringer Ingelheim, Ingelheim,
Germany; AstraZeneca, Wilmington, DE, USA




PRS31 PFSA, Boulogne Billancourt, France
PRS32 Covidien, Boulder, CO, USA
PRS33 None
PRS34 None
PRS35 Centers for Medicare and Medicaid Services, Baltimore, MD, USA
PRS36 Sunovion Pharmaceuticals Inc., Marlborough, MA, USA
PRS37 None
PRS38 None
PRS39 Fundacion PROMIGAS, Barranquilla, Colombia
PRS40 None
PRS41 Sunovion Pharmaceuticals Inc., Marlborough, MA, USA
PRS42 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
PRS43 GlaxoSmithKline, Durham, NC, USA
PRS44 Novartis Pharmaceuticals Corp., East Hanover, NJ, USA
PRS45 Pfizer, Peapack, NJ, USA
PRS46 RTI-Health Solutions, Research Triangle Park, NC, USA; GlaxoSmithKline,
Durham, NC, USA
PSS1 None
PSS2 Pfizer, La Jolla, CA, USA
PSS3 None
PSS4 Nestle´ Nutrition Institute, Vevey, Switzerland
PSS5 None
PSS6 None
PSS7 Allergan Singapore Pte Ltd., Singapore, Singapore
PSS8 Nestle´ Nutrition Institute, Vevey, Switzerland
PSS9 Healthpoint Ltd., Fort Worth, TX, USA
PSS10 Pfizer, Mexico City, Mexico
PSS11 None
PSS12 National Health and Medical Research Council, Canberra, Australia
PSS13 Allergan Inc, Irvine, CA, USA
PSS14 Novartis Pharma sa-nv, Vilvoorde, Belgium
PSS15 Pfizer, Inc., New York, NY, USA; Prevent Blindness America, Chicago, IL,
USA; NIH, Bethesda, MD, USA; NEI, Bethesda, MD, USA; Merck, Inc.,
Whitehorse Station, NJ, USA; Allergan, Inc., Irvine, CA, USA
PSS16 El Lilly & Company, Indianapolis, IN, USA
PSS17 Pfizer Inc, New London, CT, USA
PSS18 None
PSS19 Allergan, Inc., Irvine, CA, USA
PSS20 Pfizer Inc, New London, CT, USA
PSS21 Allergan Inc, Irvine, CA, USA
PSS22 Nestle´ Nutrition Institute, Vevey, Switzerland
PSS23 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PSS24 None
PSS25 None
PSS26 PFSA, Boulogne Billancourt, France
PSS27 Janssen-Cilag, Bogota, Colombia
PSS28 Pfizer Inc, La Jolla, CA, USA
PSS29 Pfizer In, New York, NY, USA
PSS30 PFSA, Boulogne Billancourt, France
PSU1 None
PSU2 Ethicon Endo-Surgery, Cincinnati, OH, USA
PSU3 National Evidence-based Healthcare Collaborating Agency, Seoul, South
Korea
PSU4 Ethicon Endo Surgery, Inc, Cincinnati, OH, USA
PSU5 National Evidence-based Healthcare Collaborating Agency, Seoul, South
Korea
PSU6 None
PSU7 Johnson & Johnson Medical Mexico, Mexico City, Mexico
PSU8 Bristol-Myers Squibb, Plainsboro, NJ, USA
PSU9 Heraeus Medical, Wehrheim, Germany
PSU10 None
PSU11 BioSense Webster, Diamond Bar, CA, USA
PSU12 None
PSU13 None
PSU14 National Kidney Foundation, Singapore, Singapore
PSU15 None
PSU16 Ethicon, Inc., Somerville, NJ, USA
PSU17 None
PSU18 None
PSU19 National Evidence-based Healthcare Collaborating Agency (NECA), Seoul,
South Korea
PSU20 National Evidence-based Healthcare Collaborating Agency, Seoul, South
Korea








PSY4 Otsuka, Rockville, MD, USA
PSY5 None
PSY6 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
PSY7 Novo Nordisk Inc., Princeton, NJ, USA
PSY8 Endo, Chadds Ford, PA, USA
PSY9 Nycomed, Madrid, Spain
PSY10 Amgen (Europe) GmbH, Zug, Switzerland
PSY11 Pfizer Pharmaceuticals Korea Ltd., Seoul, South Korea
PSY12 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PSY13 None
PSY14 Endo Pharmaceuticals, Inc., Chadds Ford, PA, USA
PSY15 None
PSY16 None
PSY17 Amgen, Mexico, Mexico
PSY18 None
PSY19 Millennium Pharmaceuticals, Inc, Cambridge, MA, USA
PSY20 Pfizer, Mexico City, Mexico
PSY21 Laboratorios Medix SA de CV, Mexico City, Mexico
PSY22 Genzyme Europe BV, Naarden, The Netherlands
PSY23 None
PSY24 Pharmaceutical Company “Sotex”, Moscow, Russia
PSY25 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PSY26 Otsuka, Rockville, MD, USA
PSY27 Pfizer, Inc., New York, NY, USA
PSY28 None
PSY29 Endo Pharmaceuticals, Inc., Chadds Ford, PA, USA
PSY30 Medco Research Institute, LLC, Bethesda, MD, USA
PSY31 Novo Nordisk, Søborg, Denmark
PSY32 None
PSY33 Forest Research Institute, Jersey City, NJ, USA
PSY34 Forest Research Institute, Jersey City, NJ, USA
PSY35 GlaxoSmithKline, Research Triangle Park, NC, USA; Human Genome
Sciences, Rockville, MD, USA
PSY36 GlaxoSmithKline, Research Triangle Park, NC, USA; Human Genome
Sciences, Rockville, MD, USA
PSY37 PFSA, Boulogne Billancourt, France
PSY38 Pfizer Pharmaceuticals Korea Ltd., Seoul, South Korea
PSY39 Bayer Schering Pharma, Berlin, Germany
PSY40 Bayer Schering Pharma, Berlin, Germany
PSY41 Bayer Schering Pharma, Berlin, Germany
PSY42 Pharmaceutical Company “Sotex”, Moscow, Russia
PSY43 Bayer Schering Pharma, Berlin, Germany
PSY44 PFSA, Boulogne Billancourt, France
PSY45 Novo Nordisk Inc, Princeton, NJ, USA
PSY46 UCB, Brussels, Belgium
PSY47 None
PSY48 Abbott Canada, Montreal, QC, Canada; Pacific Blue Cross, Vancouver, BC,
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PSY51 None
PSY52 Ortho McNeil Janssen Scientific Affairs, Raritan, NJ, USA
PSY54 None
PSY55 None




PSY60 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PSY61 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PSY62 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PSY63 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PSY64 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PSY65 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PSY66 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PSY67 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PSY68 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PSY69 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PSY70 None
PSY71 GlaxoSmithKline, Inc, Philadelphia, PA, USA
PSY72 Celgene, Summit, NJ, USA
PSY73 University of Missouri Research Board, Columbia, MO, USA
PSY74 None
PSY75 None
PSY76 Novartis Pharmaceuticals Corp., East Hanover, NJ, USA
PSY77 Takeda Pharmaceuticals International, Inc., Deerfield, IL, USA
PSY78 HQ AF Surgeon General, Washington, DC, USA
PSY79 None
PSY80 Institut fu¨r Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG), Köln,
Germany
PSY81 CSL Behring, King of Prussia, PA, USA




PUK5 Pfizer, New York, NY, USA
PUK6 None
PUK7 Amgen, Mexico, Mexico
PUK8 Bristol-Myers Squibb, Sa˜o Paulo, Brazil
PUK9 None
PUK10 Bristol-Myers Squibb, Sa˜o Paulo, Brazil
PUK11 Pfizer, Inc, New York, NY, USA
PUK12 Pfizer, Mexico City, Mexico
PUK13 Pfizer S.A, Bogota´, Colombia
PUK14 Medtronic, Inc., Minneapolis, MA, USA
PUK15 Shire Pharmaceuticals Group, Wayne, PA, USA
PUK16 Hoffmann-La Roche Ltd, Mississauga, ON, Canada
PUK17 None
PUK18 Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville,
MD, USA
PUK19 Bristol-Myers Squibb, Sa˜o Paulo, Brazil
PUK20 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA
PUK21 Pfizer, New York, NY, USA
PUK22 Intuitive Surgical, Sunnyvale, CA, USA
PUK23 Allergan, LLC, Irvine, CA, USA
PUK24 DaVita Clinical Research, Minneapolis, MN, USA
QA1 GlaxoSmithKline, Research Triangle Park, NC, USA
QA2 Hoffman-La Roche, Toronto, ON, Canada
QA3 None
QA4 ABPI, London, UK
SB1 Thomson Reuters, Cambridge, MA, USA
SB2 Ortho McNeil, Raritan, NJ, USA
SB3 Ortho-McNeil Janssen Scientific Affairs, LLC, Titusville, NJ, USA
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